Name | AKTSIONERNOE OBSCHESTVO "INSTITUT MOLEKULYARNOY DIAGNOSTIKI "DIAFARM" |
|---|
INN | 7728036446 |
|---|
KPP | 770101001 |
|---|
OGRN | 1037739126347 |
|---|
OKPO | 27952591 |
|---|
FFSM | 13676-H |
|---|
Address | 105064, G.moskva, per. Gorokhovskiy, d. D. 12, of. ETAZH 3 POM 302 |
|---|
Phone | 762-95-90 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 21.20 | Core activity | Manufacturers of drugs and pharmaceuticals and medical products | | 46.19 | Additional activity | Activity of agents in wholesale trade of universal assortment of goods | | 46.90 | Additional activity | Nonspecialised wholesale trade | | All types of activities | | 47.73 | Additional activity | Retailing drugs in specialized stores (pharmacies) | | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | | 63.11.1 | Additional activity | Data processing, hosting and related activities | | 70.22 | Additional activity | Advice on business and management | | 72.19 | Additional activity | Research and experimental development on natural sciences and engineering Other | | 85.42.9 | Additional activity | Activities for additional professional education, not included in other categories |
Registration date | 17.01.2003 |
|---|
Registering department | Gosudarstvennoe uchrezhdenie Moskovskaya registratsionnaya palata |
|---|
|
AO "DIAFARM" (Moscow; INN 7728036446) was registered on 17 Jan 2003. The company's authorized capital as of July 1, 2012 was 22220 rub. Type of ownership of AO "DIAFARM" - Closed joint-stock companies. Form of ownership of AO "DIAFARM" - Private property. Principal activities of AO "DIAFARM": manufacturers of drugs and pharmaceuticals and medical products (21.20), activity of agents in wholesale trade of universal assortment of goods (46.19), nonspecialised wholesale trade (46.90). |
Economic indicators2022
Net profit (RAS) of AO DIAFARM made up 25.19 million RUB over 2022 compared to net loss of 54.00 thousand RUB over 2021, the company informed. Revenue increased in the accounting period by 29.21% to 123.48 million RUB from 95.57 million RUB over 2021; cost of goods sold decreased by 3.38% to 80.57 million RUB from 83.40 million RUB; sales profit made up 24.05 million RUB compared to sales loss of 2.36 million RUB. 2021
Net loss (RA) of AO DIAFARM made up 54.00 thousand RUB over 2021 compared to net profit of 6.27 million RUB over 2020, the company informed. Revenue increased in the accounting period by 14.46% to 95.57 million RUB from 83.50 million RUB over 2020; cost of goods sold grew by 28.56% to 83.40 million RUB from 64.87 million RUB; sales loss made up 2.36 million RUB compared to sales profit of 4.54 million RUB. 2020
Net profit (RAS) of AO DIAFARM grew over 2020 1.93 times to 6.27 million RUB from 3.25 million RUB over 2019, the company informed. Revenue decreased in the accounting period by 15.29% to 83.50 million RUB from 98.57 million RUB in 2019; cost of goods sold decreased by 6.71% to 64.87 million RUB from 69.53 million RUB; sales profit went up 2.11 times to 4.54 million RUB from 2.15 million RUB. 2019
Net profit (RAS) of AO DIAFARM dropped in 2019 by 48.13% to 3.25 million RUB from 6.27 million RUB over the same period in 2018, the company informed. Revenue increased in the accounting period by 8.92% to 98.57 million RUB from 90.49 million RUB over 2018; cost of goods sold grew by 49.78% to 69.53 million RUB from 46.42 million RUB; sales profit fell by 47.19% to 2.15 million RUB from 4.08 million RUB. 2018
Net profit (RAS) of AO DIAFARM dropped in 2018 3.13 times to 6.27 million RUB from 19.60 million RUB over the same period in 2017, the company informed. Revenue decreased in the accounting period by 14.19% to 90.49 million RUB from 105.46 million RUB in 2017; cost of goods sold decreased by 13.55% to 46.42 million RUB from 53.70 million RUB; sales profit fell 3.28 times to 4.08 million RUB from 13.36 million RUB. 2017
Net profit (RAS) of AO DIAFARM dropped in 2017 2.16 times to 19.60 million RUB from 42.33 million RUB over the same period in 2016, the company informed. Revenue decreased in the accounting period by 13.69% to 105.46 million RUB from 122.19 million RUB in 2016; cost of goods sold grew by 17.43% to 92.10 million RUB from 78.43 million RUB; sales profit fell 3.28 times to 13.36 million RUB from 43.75 million RUB. 2016
Net profit (RAS) of DIAFARM, ZAO dropped in 2016 2.91 times to 42.33 million RUB from 123.36 million RUB over the same period in 2015, the company informed. Revenue decreased in the accounting period by 48.75% to 122.19 million RUB from 238.41 million RUB in 2015; cost of goods sold decreased by 8.88% to 78.43 million RUB from 86.08 million RUB; sales profit fell 3.48 times to 43.75 million RUB from 152.33 million RUB. 2014
Net profit (RAS) of Diafarm, ZAO grew over 2014 8.79 times to 47.59 million RUB from 5.41 million RUB over 2013, the company informed. Revenue increased in the accounting period 2.44 times to 128.75 million RUB from 52.71 million RUB over 2013; cost of goods sold grew 1.57 times to 69.59 million RUB from 44.27 million RUB; sales profit went up 7.01 times to 59.15 million RUB from 8.44 million RUB. 2013
Net profit (RAS) of Diafarm, ZAO grew over 2013 by 20.72% to 5.41 million RUB from 4.48 million RUB over 2012, the company informed. Revenue increased in the accounting period by 4.60% to 52.71 million RUB from 50.39 million RUB over 2012; cost of goods sold grew by 1.29% to 44.27 million RUB from 43.70 million RUB; sales profit went up by 26.22% to 8.44 million RUB from 6.69 million RUB. 2012
Net profit (RAS) of DIAFARM, ZAO grew over 2012 1.58 times to 4.48 million RUB from 2.85 million RUB over 2011, the company informed. Revenue increased in the accounting period by 30.75% to 50.39 million RUB from 38.54 million RUB over 2011; cost of goods sold grew by 30.33% to 43.70 million RUB from 33.53 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|